We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IP:MILInterpump Group S.p.A. Analysis

Data as of 2026-05-27 - not real-time

€36.40

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Interpump Group trades at €36.4, just above its 20‑day SMA (€35.58) and 50‑day SMA (€35.17) but still below the 200‑day SMA (€40.77), indicating a short‑term bounce within a longer‑term downtrend. The RSI sits at 53.6, suggesting neutral momentum, while the MACD histogram is positive and the signal line turned bullish, reinforced by rising volume – a modest technical upside toward the resistance at €37.26.
Fundamentally, the stock appears fairly priced on a relative basis (PE 18.6 vs industry average 30.2) yet the DCF fair value of €28.07 signals a potential overvaluation of roughly 30% at current levels. Strong cash generation (operating cash flow €321.7 M, free cash flow €242.6 M), a low payout ratio (16.9%) and a dividend yield of 0.97% support dividend sustainability. With modest revenue growth (0.6%), solid margins (gross 35%, operating 15.8%) and a low debt‑to‑equity of 31.5%, the company offers a stable earnings base, though high 30‑day volatility (43%) and a beta below 1 suggest moderate market risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD crossover with increasing volume
  • Price near short‑term resistance at €37.26
  • Neutral RSI indicating limited upside momentum

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Attractive PE relative to industry peers
  • Sustainable dividend and low payout ratio
  • Strong cash flow generation supporting earnings growth

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Diversified global footprint reducing single‑market exposure
  • Stable margins and modest but consistent revenue growth
  • Elevated valuation versus DCF fair value suggesting limited upside

Key Metrics & Analysis

Financial Health

Revenue Growth0.60%
Profit Margin10.05%
P/E Ratio18.6
ROE9.99%
ROA5.98%
Debt/Equity31.50
P/B Ratio1.8
Op. Cash Flow€321.7M
Free Cash Flow€242.6M
Industry P/E30.2

Technical Analysis

TrendNeutral
RSI53.6
Support€30.92
Resistance€37.26
MA 20€35.58
MA 50€35.17
MA 200€40.77
MACDBullish
VolumeIncreasing
Fear & Greed Index91.98

Valuation

Fair Value€28.07
Target Price€45.56
Upside/Downside25.17%
GradeOvervalued
TypeBlend
Dividend Yield0.97%

Risk Assessment

Beta0.70
Volatility43.45%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.